BAUAX
Price
$31.95
Change
+$0.07 (+0.22%)
Updated
Jul 31 closing price
Net Assets
1.24B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

BAUAX vs VSCIX

BAUAX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
BAUAX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAUAX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. BAUAX (1.24B). VSCIX pays higher dividends than BAUAX: VSCIX (1.23) vs BAUAX (0.40). BAUAX was incepted earlier than VSCIX: BAUAX (15 years) vs VSCIX (29 years). BAUAX (1.36) is less costly to investors than VSCIX (0.03). BAUAX is a more actively managed with annual turnover of: 39.00 vs. VSCIX (17.00). BAUAX has a lower initial minimum investment than VSCIX: BAUAX (100) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. BAUAX (15.87). VSCIX return over 5 years is better than : 35.13 vs. BAUAX (12.97).
BAUAXVSCIXBAUAX / VSCIX
Total Expense Ratio1.360.034,533%
Annual Report Gross Expense Ratio1.360.034,533%
Fund Existence15 years29 years-
Gain YTD21.76114.591149%
Front LoadN/AN/A-
Min. Initial Investment10050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B189B1%
Annual Yield % from dividends0.401.2333%
Returns for 1 year15.8722.5870%
Returns for 3 years12.1343.4428%
Returns for 5 years12.9735.1337%
Returns for 10 years42.61156.0727%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C